Detection of breast cancer (BrCa) cells in patient peripheral blood stem cell (PBSC) and CD34 selected products using immunocytochemical (ICC) and tumor enrichment procedures.

被引：0
|
作者：
Umiel, T
Prilutskaya, M
Nguyen, NH
Moss, TJ
Burgess, J
Griffith, M
Mills, BJ
机构：
[1] Impath BIS Inc, Reseda, CA USA
[2] Nexell Therapeut Inc, Irvine, CA USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1843
引用
收藏
页码：446A / 446A
页数：1
相关论文
共 50 条
  • [41] Research report - Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique
    Dal Cortivo, L
    Cottu, PH
    Lotz, JP
    Robert, I
    Extra, JM
    Miclea, JM
    Marty, M
    Marolleau, JP
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (06): : 855 - 862
  • [42] Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction
    Mapara, MY
    Korner, IJ
    Hildebrandt, M
    Bargou, R
    Krahl, D
    Reichardt, P
    Dorken, B
    BLOOD, 1997, 89 (01) : 337 - 344
  • [43] The presence of clonogenic breast cancer cells in peripheral blood stem cell (PBSC) products correlates with an extremely poor prognosis for patients with stage IV disease.
    Moss, TJ
    Umiel, T
    Herzig, RM
    Meaghar, R
    Cooper, B
    Kennedy, MJ
    Meagher, R
    Petri, RA
    Percora, A
    Copelan, E
    Lazarus, HM
    Rosenfeld, C
    BLOOD, 1997, 90 (10) : 4570 - 4570
  • [44] CEA RT-PCR is a sensitive method to detect breast tumor cells in peripheral blood and in progenitor cell collections prior to and following CD34(+) cell selection.
    Salmon, MA
    Jurdan, M
    Brasseur, F
    Feyens, AF
    Symann, M
    BLOOD, 1997, 90 (10) : 4342 - 4342
  • [45] Processing of G-CSF Mobilized Peripheral Blood Stem Cells (PBSC) from Parental Haploidentical Sickle Cell Trait Donors Undergoing CD34 Enrichment with T cell Addback in Children, Adolescents and Adults with HighRisk Sickle Cell Disease (IND 14359)
    Ayello, J.
    Keever-Taylor, C.
    Weinberg, R.
    Grossman, B. J.
    Shenoy, S.
    Talano, J.
    Moore, T. B.
    Fabricatore, S.
    Semidei-Pomales, M.
    Cairo, M.
    TRANSFUSION, 2016, 56 : 5A - 5A
  • [46] Early and late hematopoietic recovery according to CD34+ cell dose in patients with high-risk breast cancer following autologous peripheral blood stem cell (PBSC) rescue
    Cobo, M
    Benavides, M
    Carabantes, F
    Trujillo, R
    Gomez, D
    Breton, JJ
    Paredes, G
    Bailen, A
    Juarez, C
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [47] Additonal depletion of residual T cells from CD34 positively selected peripheral blood progenitor cells is necessary to achieve low T cell doses in some apheresis products.
    Collins, NH
    Bleau, SA
    Charles, CM
    Gemelli, P
    Smith, KM
    Alpdogan, O
    O'Reilly, RJ
    BLOOD, 2000, 96 (11) : 184A - 184A
  • [48] Mobilization of peripheral blood CD34 stem cells in a heavily pre-treated pediatric medulloblastoma patient using AMD3100 and G-CSF
    Robertson, KA
    Pradhan, K
    Goebel, S
    Renbarger, J
    Abonour, R
    Calandra, GB
    McFarland, RT
    Haut, PR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 75 - 76
  • [49] Immunomagnetic enrichment of CD34(+) peripheral blood progenitor cells in breast cancer patients: Monitoring of purging efficiency by cytokeratin 19 and EGF-R based RT-PCR
    Mapara, MY
    Korner, IJ
    Hildebrandt, M
    Bargou, R
    Dorken, B
    BLOOD, 1995, 86 (10) : 922 - 922
  • [50] Peripheral blood stem cell (PBSC) products and ex vivo expanded CD34+ cells in multiple myeloma (MM) patients do not show the presence of KSHV DNA sequences.
    De Greef, C
    Bakkus, M
    Heirman, C
    Schots, R
    Lacor, P
    Van Camp, B
    Van Riet, I
    BONE MARROW TRANSPLANTATION, 1998, 21 : S207 - S207
12345